Patents by Inventor Astrid Volz

Astrid Volz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sulfated Benzimidazolone Derivatives Having Mixed Serotonine Receptor Affinity
    Publication number: 20150368204
    Abstract: The present invention pertains to a compound of formula (I) wherein R1, R2, R3, and R4 are each hydrogen or sulfate monoester with the proviso that R1, R2, R3, and R4 cannot simultaneously be hydrogen, processes for their preparation and their use as pharmaceuticals in the treatment of CNS disorders.
    Type: Application
    Filed: April 20, 2015
    Publication date: December 24, 2015
    Inventors: Astrid Volz, Ralf Lotz, Fabio Paleari
  • Sulfated Benzimidazolone Derivatives Having Mixed Serotonine Receptor Affinity
    Publication number: 20150011564
    Abstract: The present invention pertains to a compound of formula (I) wherein R1, R2, R3, and R4 are each hydrogen or sulfate monoester with the proviso that R1, R2, R3, and R4 cannot simultaneously be hydrogen, processess for their preparation and their use as pharmaceuticals in the treatment of CNS disorders.
    Type: Application
    Filed: May 8, 2014
    Publication date: January 8, 2015
    Applicant: Sprout Pharmaceuticals, Inc.
    Inventors: Astrid Volz, Ralf Lotz, Fabio Paleari
  • Sulfated benzimidazolone derivatives having mixed serotonin receptor affinity
    Patent number: 8722682
    Abstract: The present invention pertains to a compound of formula (I) wherein R1, R2, R3, and R4 are each hydrogen or sulfate monoester with the proviso that R1, R2, R3, and R4 cannot simultaneously be hydrogen, processess for their preparation and their use as pharmaceuticals in the treatment of CNS disorders.
    Type: Grant
    Filed: December 18, 2007
    Date of Patent: May 13, 2014
    Assignee: Sprout Pharmaceuticals, Inc.
    Inventors: Astrid Volz, Ralf Lotz, Fabio Paleari
  • SULFATED BENZIMIDAZOLONE DERIVATIVES HAVING MIXED SEROTONINE RECEPTOR AFFINITY
    Publication number: 20110015207
    Abstract: The present invention pertains to compounds of general formula (I) wherein R1, R2, R3, and R4 denote hydrogen or sulfate monoester with the proviso that R1, R2, R3, and R4 cannot simultaneously represent hydrogen, processes for their preparation and their use as pharmaceuticals.
    Type: Application
    Filed: December 18, 2007
    Publication date: January 20, 2011
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Astrid Volz, Ralf Lotz, Fabio Paleari